FMR LLC reports 7% stake in Solid Biosciences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC and Abigail P. Johnson report beneficial ownership of Solid Biosciences Inc. common stock on a Schedule 13G. As of June 30, 2026, they beneficially owned 6,875,956.68 shares of common stock, representing 7.0% of the class.
FMR LLC reports sole voting power over 6,875,423 shares and sole dispositive power over 6,875,956.68 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over 6,875,956.68 shares and no voting power, reflecting her control position over FMR entities.
The filing notes that one or more other persons have rights to receive dividends or sale proceeds from these shares, but no single such person has an interest exceeding five percent of Solid Biosciences’ outstanding common stock. The securities were acquired and are reported through subsidiaries identified in an attached Exhibit 99.
Key Figures
Key Terms
beneficially owned financial
sole dispositive power financial
sole voting power financial
Schedule 13G regulatory
parent holding company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Solid Biosciences Inc (SLDB) stock does FMR LLC report owning?
What percentage of Solid Biosciences Inc (SLDB) does Abigail P. Johnson report on this Schedule 13G?
What subsidiaries are involved in the SLDB holdings reported by FMR LLC?
AI-generated analysis. How Rhea-AI works. Not financial advice.